Lemaitre Vascular (LMAT) Gains from Investment Securities (2010 - 2026)
Lemaitre Vascular (LMAT) reported Gains from Investment Securities of $687000.0 for Q1 2026, up 92612.55% year-over-year from N/an in Q1 2025, and down 90.66% quarter-over-quarter from $7.4 million in Q4 2025.
Lemaitre Vascular (LMAT) Gains from Investment Securities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Gains from Investment Securities data on file, last reported at $687000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $687000.0, up 92612.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 million (up 926620.65% YoY), and the FY2025 annual result was $886363.0, up 604.39% from the prior year.
- Gains from Investment Securities fell to $687000.0 in Q1 2026 per LMAT's latest filing, from $7.4 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $7.4 million in Q4 2025 and troughed at -$1.2 million in Q4 2024.
- A 5-year average of $916937.1 and a median of $1322.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2024 and 2026: Gains from Investment Securities tumbled 120.11% in 2024, then surged 92612.55% in 2026.
- A 5-year view of Gains from Investment Securities shows it stood at -$100000.0 in 2022, then surged by 6063.0% to $6.0 million in 2023, then plunged by 120.11% to -$1.2 million in 2024, then surged by 713.51% to $7.4 million in 2025, then tumbled by 90.66% to $687000.0 in 2026.
- Business Quant data shows LMAT's Gains from Investment Securities at $687000.0 in Q1 2026, $7.4 million in Q4 2025, and $741.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 687,000.00 |
| Mar 31, 2026 | 687,000.00 |
| Dec 31, 2025 | 7.36 Mn |
| Dec 31, 2025 | 7.36 Mn |
| Sep 30, 2025 | 741.00 |
| Sep 30, 2025 | 741.00 |
| Jun 30, 2025 | 741.00 |
| Jun 30, 2025 | 741.00 |
| Mar 31, 2025 | 741.00 |
| Mar 31, 2025 | 741.00 |
| Dec 31, 2024 | -1.20 Mn |
| Dec 31, 2024 | -1.20 Mn |
| Mar 31, 2024 | 23,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | 5.96 Mn |
| Dec 31, 2023 | 5.96 Mn |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 1,660.00 |
| Jun 30, 2023 | 1,660.00 |